The DOI matches its Crossref record; 220 of the 220 references it cites were found in a registry or an index.
Pathological implication of protein post-translational modifications in cancer
Open accessAbstract
Protein post-translational modifications (PTMs) profoundly influence protein functions and play crucial roles in essentially all cell biological processes. The diverse realm of PTMs and their crosstalk is linked to many critical signaling events involved in neoplastic transformation, carcinogenesis and metastasis. The pathological roles of various PTMs are implicated in all aspects of cancer hallmark functions, cancer metabolism and regulation of tumor microenvironment. Study of PTMs has become an important area in cancer research to understand cancer biology and discover novel biomarkers and therapeutic targets. With a limited scope, this review attempts to discuss some PTMs of high frequency with recognized importance in cancer biology, including phosphorylation, acetylation, glycosylation, palmitoylation and ubiquitination, as well as their implications in clinical applications. These protein modifications are among the most abundant PTMs and profoundly implicated in carcinogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–220 of 220
A Combined Shotgun and Targeted Mass Spectrometry Strategy for Breast Cancer Biomarker Discovery
Sjöström, M., Ossola, R., Breslin, T., Rinner, O., Malmström, L., Schmidt, A., Aebersold, R. H., Malmström, J. A., & Niméus, E. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00315 · Cited by 39
Lysine Acetylation, Cancer Hallmarks and Emerging Onco-Therapeutic Opportunities
Hu, M., He, F.-L., Thompson, E. W., Ostrikov, K., & Dai, X. (2022) · Cancers · doi:10.3390/cancers14020346 · Cited by 38
Proteome alterations in pancreatic ductal adenocarcinoma
Pan, S., Brentnall, T. A., & Chen, R. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.11.020 · Cited by 36
Self-citationSimithy, J., Sidoli, S., & Garcia, B. A. (2018) · PROTEOMICS · doi:10.1002/pmic.201700309 · Cited by 34
Advances in quantitative high‐throughput phosphoproteomics with sample multiplexing
Paulo, J. A., & Schweppe, D. K. (2021) · PROTEOMICS · doi:10.1002/pmic.202000140 · Cited by 34
Towards single-cell LC-MS phosphoproteomics
Polat, A. N., & Özlü, N. (2014) · The Analyst · doi:10.1039/c4an00463a · Cited by 33
Indellicato, R., Zulueta, A., Caretti, A., & Trinchera, M. (2020) · Cancers · doi:10.3390/cancers12061509 · Cited by 33
Protein Acetylation at the Interface of Genetics, Epigenetics and Environment in Cancer
Harachi, M., Masui, K., Cavenee, W. K., Mischel, P. S., & Shibata, N. (2021) · Metabolites · doi:10.3390/metabo11040216 · Cited by 32
Novel regulation of Ras proteins by direct tyrosine phosphorylation and dephosphorylation
Buday, L., & Vas, V. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09918-2 · Cited by 31
Wnt Lipidation and Modifiers in Intestinal Carcinogenesis and Cancer
Kaemmerer, E., & Gaßler, N. (2016) · Cancers · doi:10.3390/cancers8070069 · Cited by 30
AGO2 promotes tumor progression in KRAS-driven mouse models of non–small cell lung cancer
Tien, J. C.-Y., Chugh, S., Goodrum, A. E., Cheng, Y., Mannan, R., Zhang, Y., Wang, L., Dommeti, V. L., Wang, X., Xu, A., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2026104118 · Cited by 28
Filosa, G., Barabino, S. M. L., & Bachi, A. (2013) · NeuroMolecular Medicine · doi:10.1007/s12017-013-8256-8 · Cited by 25
Orlando, R. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-454-8_3 · Cited by 21
Wang, X., & Zhao, J. (2022) · Cancer Management and Research · doi:10.2147/cmar.s346052 · Cited by 19
Zhu, H., Qiu, C., Gryniewicz-Ruzicka, C. M., Keire, D. A., & Ye, H. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c00014 · Cited by 16
Wang, Z., & Schey, K. L. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-25312 · Cited by 11
Protein Lipidation As a Regulator of Apoptotic Calcium Release: Relevance to Cancer
Chen, J. J., & Boehning, D. F. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00138 · Cited by 9
Glycoproteomics Technologies in Glycobiotechnology
Alagesan, K., Hoffmann, M., Rapp, E., & Kolarich, D. (2020) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2020_144 · Cited by 9
Kang, C., & Yi, G. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-s14-s8 · Cited by 6
Brooksbank, C. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35056503 · Cited by 4
Cited by
Zhong, Q., Xiao, X., Qiu, Y., Xu, Z., Chen, C., Chong, B., Zhao, X., Hai, S., Li, S., An, Z., et al. (2023) · MedComm · doi:10.1002/mco2.261 · Cited by 442
Liu, R., Wu, J., Guo, H., Yao, W., Li, S., Lu, Y., Jia, Y., Liang, X., Tang, J., & Zhang, H. (2023) · MedComm · doi:10.1002/mco2.292 · Cited by 264
Systematic identification of structure-specific protein–protein interactions
(2024) · doi:10.1038/s44320-024-00037-6 · Cited by 34
Sun, X., Zhang, K., Peng, X., Zhou, P., Qu, C., Yang, L., & Shen, L. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216158 · Cited by 21
Targeted protein modification as a paradigm shift in drug discovery
Amirian, R., Azadi Badrbani, M., Izadi, Z., Samadian, H., Bahrami, G., Sarvari, S., Abdolmaleki, S., Nabavi, S. M., Derakhshankhah, H., & Jaymand, M. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115765 · Cited by 18
Metadata
- Authors
- Pan, S., & Chen, R.
- Venue
- Molecular Aspects of Medicine
- Publisher
- Elsevier BV
- Published
- 2022-08
- Volume
- 86
- Pages
- 101097
- ISSN
- 0098-2997 (ISSN-L)
- OpenAlex
- W4223515782
- Cited by
- 263
- References
- 220
- FWCI
- 13.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.